146 related articles for article (PubMed ID: 38426683)
1. [Apheresis Techniques for the Treatment of Hyperbilirubinemia in the Nephrology Unit].
de Pascale E; Marinelli G; Iulianiello P; Matrisciano R; Viggiano D; Pluvio C
G Ital Nefrol; 2024 Feb; 41(1):. PubMed ID: 38426683
[TBL] [Abstract][Full Text] [Related]
2. A comparison among three different apheretic techniques for treatment of hyperbilirubinemia.
Viggiano D; de Pascale E; Marinelli G; Pluvio C
J Artif Organs; 2018 Mar; 21(1):110-116. PubMed ID: 28887736
[TBL] [Abstract][Full Text] [Related]
3. Bilirubin Adsorption with DPMAS: Mechanism of Action and Efficacy of Anion Exchange Resin.
Marcello M; Ronco C
Contrib Nephrol; 2023; 200():201-209. PubMed ID: 37263196
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial.
Wallon G; Guth C; Guichon C; Thevenon S; Gazon M; Viale JP; Schoeffler M; Duperret S; Aubrun F
Blood Purif; 2022; 51(3):243-250. PubMed ID: 34139706
[TBL] [Abstract][Full Text] [Related]
5. Divide et Vinces, Therapeutic Apheresis in Nephrological Clinical Practice.
Mantilla J; Peña D; Molano-Triviño A; Zúñiga E; Castellanos-De La Hoz JC
Blood Purif; 2024; 53(3):162-169. PubMed ID: 38113864
[TBL] [Abstract][Full Text] [Related]
6. Bilirubin adsorption versus plasma exchange for hyperbilirubinemia in patients after cardiac surgery: a retrospective study.
Pan K; Zhang H; Zhong K; Zhang HT; Li ZS; Chen Z; Gu SP; Xie M; Pan T; Cao HL; Wang DJ
J Cardiothorac Surg; 2021 Aug; 16(1):238. PubMed ID: 34425880
[TBL] [Abstract][Full Text] [Related]
7. Depurative capacity of molecular adsorbent recycling system (MARS): A focus on bilirubin removal.
Gong D; Cruz D; Ronco C
Int J Artif Organs; 2008 Oct; 31(10):875-81. PubMed ID: 19009505
[TBL] [Abstract][Full Text] [Related]
8. Decline in plasma retinol in unconjugated hyperbilirubinemia treated with bilirubin adsorption using an anion-exchange resin.
Ihara H; Shino Y; Hashizume N; Aoki T; Suzuki Y; Igarasi Y; Naito C
J Nutr Sci Vitaminol (Tokyo); 1998 Apr; 44(2):329-36. PubMed ID: 9675713
[TBL] [Abstract][Full Text] [Related]
9. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
10. [Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].
Avilés J; Macía M; Morales S; Pérez F; Moreno A; Navarro J; Navazo L; García J
Nefrologia; 2001; 21(4):376-85. PubMed ID: 11816514
[TBL] [Abstract][Full Text] [Related]
11. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.
Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL
Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264
[TBL] [Abstract][Full Text] [Related]
12. Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin.
Lee KH; Wendon J; Lee M; Da Costa M; Lim SG; Tan KC
Liver Transpl; 2002 Jul; 8(7):591-3. PubMed ID: 12089711
[TBL] [Abstract][Full Text] [Related]
13. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.
Mitzner SR; Stange J; Klammt S; Risler T; Erley CM; Bader BD; Berger ED; Lauchart W; Peszynski P; Freytag J; Hickstein H; Loock J; Löhr JM; Liebe S; Emmrich J; Korten G; Schmidt R
Liver Transpl; 2000 May; 6(3):277-86. PubMed ID: 10827226
[TBL] [Abstract][Full Text] [Related]
14. Significant decrease in dialysate albumin concentration during molecular adsorbent recirculating system (M.A.R.S.) therapy.
Gong D; Ji D; Ren B; Tao J; Xu B; Ronco C; Li L
Int J Artif Organs; 2008 Apr; 31(4):333-9. PubMed ID: 18432590
[TBL] [Abstract][Full Text] [Related]
15. [Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters].
Mitzner S; Klammt S; Stange J; Nöldge-Schomburg GF; Schmidt R
Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):199-206. PubMed ID: 15832238
[TBL] [Abstract][Full Text] [Related]
16. [Is apheresis still a useful tool in the treatment of nephrological diseases?].
Santoro A
G Ital Nefrol; 2019 Apr; 36(2):. PubMed ID: 30983168
[TBL] [Abstract][Full Text] [Related]
17. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure--a prospective, randomised crossover study.
Sponholz C; Matthes K; Rupp D; Backaus W; Klammt S; Karailieva D; Bauschke A; Settmacher U; Kohl M; Clemens MG; Mitzner S; Bauer M; Kortgen A
Crit Care; 2016 Jan; 20():2. PubMed ID: 26728364
[TBL] [Abstract][Full Text] [Related]
18. [Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement].
Marangoni R
G Ital Nefrol; 2007; 24 Suppl 38():92-6. PubMed ID: 17922457
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS).
Mitzner SR
Ann Hepatol; 2011 May; 10 Suppl 1():S21-8. PubMed ID: 21566251
[TBL] [Abstract][Full Text] [Related]
20. [Organ replacement therapy - extracorporeal liver assist devices].
Sinner B; Kirchner GI
Anasthesiol Intensivmed Notfallmed Schmerzther; 2016 Sep; 51(9):554-62. PubMed ID: 27631450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
